So we could expect an immediate EUA...... and come mid August approval for agvhd - followed by label extention once the full phase 3 trial is completed?
Is there any difference between EUA and full approval from mesoblasts point of view?
clinicaltrials.gov - MSCs in COVID-19 ARDS, page-103
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.005(0.39%) |
Mkt cap ! $1.478B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.27 | $1.006M | 783.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 5559 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 45279 | 11 |
View Market Depth
| Last trade - 13.12pm 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |